Now you can perform high-throughput, non-invasive & high-speed imaging with excellent accuracy
SCREEN technology is applicable for various applications such as, skin irritation tests (Cosmetic industry), angiogenesis for monitoring vasculature formation and evaluating antiangiogenic molecules (ex vivo assays), drug screening, efficacy and profiling, neurite outgrowth assays and many more...
May 5-7, 2021
SCREEN and our distribution partner, Quantam Design GmbH are pleased to welcome you to our virtual booth.
SCREEN technology experts are continuously working on developing niche technologies for 3D cell culture imaging. Our poster depicts the research and applications of our Infra-red laser based OCT platform for 3D ex vivo studies.We look forward to welcoming you to our poster session:
Novel Optical Coherence Tomography (OCT) technology for non-invasive 3D ex vivo imaging. Akihiro Ueda, Takemitsu Muira, Yasushi Kuromi , Yuki Mori, Hiroki Fujimoto and Sumeer Dhar
The SCREEN Group traces its history back 150 years to Ishida Kyokuzan Printing Works, a lithographic printing shop founded in Kyoto in 1868. In 1934, we succeeded in producing Japan’s first photographic glass screens, eventually leading to our R&D division being spun off as an independent venture company in 1943 to become Dainippon Screen Mfg. Co., Ltd. Our corporate name actually originated with those first glass screens.
Through the years, the SCREEN Group has continued to meet the rapidly changing needs of various fields, including the electronics industry, particularly in the semiconductor and display markets, and the printing industry, our foundational business area. Our cutting-edge solutions have also enabled us to open up a range of innovative new areas. From our humble origins, we have grown steadily to become a global enterprise with numerous products that hold top shares in their respective markets.
